{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:10:01Z","timestamp":1788516601373,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","award":["30641"],"award-info":[{"award-number":["30641"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013392","name":"Quebec Ministry of Health and Social Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020951","name":"Fonds de recherche du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.vaccine.2025.127893","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:54:24Z","timestamp":1761789264000},"page":"127893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Long term immunogenicity of two doses of the quadrivalent HPV vaccine and the effect of an additional dose given five years post-primary vaccination"],"prefix":"10.1016","volume":"68","author":[{"given":"Chantal","family":"Sauvageau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia Gabriela","family":"Ionescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manale","family":"Ouakki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitika","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Gilca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Mayrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2025.127893_bb0025","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/S2214-109X(24)00477-7","article-title":"Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9\u201314 years: results of the long-term extension of the DoRIS randomised trial","volume":"13","author":"Watson-Jones","year":"2025","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127893_bb0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.vaccine.2022.11.044","article-title":"Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination","volume":"41","author":"Joshi","year":"2023","journal-title":"Vaccine"},{"issue":"67","key":"10.1016\/j.vaccine.2025.127893_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jncimonographs\/lgae042","article-title":"A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination","volume":"2024","author":"Malvi","year":"2024","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127893_bb0040","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1016\/S2214-109X(22)00309-6","article-title":"Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial","volume":"10","author":"Watson-Jones","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127893_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100401","article-title":"Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries","volume":"23","author":"Kjaer","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2025.127893_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113136","article-title":"Multiplex immunoassay to measure antibody response to nine HPV vaccine types","volume":"498","author":"Panicker","year":"2021","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127893_bb0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41541-024-00949-2","article-title":"WHO international standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58","volume":"9","author":"Kemp","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127893_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.19095","article-title":"Protection against persistent HPV-16\/18 infection after different number of doses of quadrivalent vaccine in girls and young women: a randomized clinical trial","volume":"8","author":"Sauvageau","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127893_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pvr.2020.100203","article-title":"Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: interim analysis after 8 years of follow-up","volume":"10","author":"Olsson","year":"2020","journal-title":"Papillomavirus Res"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127893_bb0080","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/jnci\/djaa011","article-title":"Evaluation of durability of a single dose of the bivalent HPV vaccine: the CVT trial","volume":"112","author":"Kreimer","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127893_bb0085","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41591-023-02658-0","article-title":"Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results","volume":"29","author":"Barnabas","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127893_bb0090","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.vaccine.2019.12.017","article-title":"Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: a systematic review of evidence from clinical trials","volume":"38","author":"Whitworth","year":"2020","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2025.127893_bb0095","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/j.vaccine.2017.12.079","article-title":"Explanations for the high potency of HPV prophylactic vaccines","volume":"36","author":"Schiller","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127893_bb0100","first-page":"328","article-title":"Enqu\u00eate qu\u00e9b\u00e9coise sur la sant\u00e9 de la population 2020-2021","author":"Camirand","year":"2023","journal-title":"Institut de la statistique du Qu\u00e9bec"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:29:50Z","timestamp":1781663390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25011909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":14,"alternative-id":["S0264410X25011909"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127893","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term immunogenicity of two doses of the quadrivalent HPV vaccine and the effect of an additional dose given five years post-primary vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127893"}}